NSAID-induced liver damage with cholestasis
- 2 October 2021
- journal article
- Published by Alfmed LLC in Medical alphabet
- No. 23,p. 37-48-48
Abstract
He liver is one of the organs most often affected by medication (MP) intake. Drug-induced liver damage with cholestasis (LIPCH), on the one hand, rarely leads to death in comparison with the hepatocellular type, but, on the other hand, is more often characterized by a long, in some cases chronic course. This type of liver damage is characterized by an increase in the activity of alkaline phosphatase (ALP) > 2 upper limits of normal (ULN) or the ratio of alanine aminotransferase (ALT) / ALP < 2 in chronic course. Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most readily available (including over-the-counter) and widely used drugs in clinical practice and are often the cause of LIPCH. This article summarizes the available data at the time of preparation of the article on the prevalence, mechanisms of development and features of LIPPH while taking NSAIDs. A separate section is highlighted on the features of the management of such patients. In particular, in accordance with both domestic and foreign clinical guidelines for the drug genesis of liver damage, it is recommended to stop taking the inducer drug and prescribe ursodeoxycholic acid (UDCA). The efficacy of UDCA in patients with LIPCH, including those associated with the use of NSAIDs, has been confirmed by the results of a large number of randomized placebo-controlled clinical trials. Among the UDCA preparations on the market of the Russian Federation, one cannot fail to pay attention to Exho® (CJSC «Canonpharma Production»), which is bioequivalent to the reference drug, is produced in compliance with GMP standards on a high-tech production base, which ensures its quality, and an affordable price and a large the choice of dosage forms makes it possible to successfully use this drug, including in special categories of patients, for example, elderly patients and/or those suffering from dysphagia.Keywords
This publication has 94 references indexed in Scilit:
- Adverse drug reactions associated with the use of NSAIDs: a case/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002–2006Fundamental & Clinical Pharmacology, 2011
- Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United StatesGastroenterology, 2008
- Mechanisms of NSAID-Induced HepatotoxicityDrug Safety, 2002
- Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trialJournal of Hepatology, 2000
- Update of Hepatotoxicity Due to Classes of Drugs in Common Clinical Use: Non-Steroidal Drugs, Anti-Inflammatory Drugs, Antibiotics, Antihypertensives, and Cardiac and Psychotropic AgentsSeminars in Liver Disease, 1990
- Criteria of drug-induced liver disordersJournal of Hepatology, 1990
- Diclofenac associated hepatitisJournal of Hepatology, 1990
- Toxic Effects of Nonsteroidal Anti-Inflammatory Drugs in OverdoseDrug Safety, 1990
- PiroxicamDrugs, 1981
- Fatal hepatitis probably due to indomethacinJAMA, 1967